Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for Prevention of Lung Injury in Lung Resection
NCT00655928Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Aug 2007
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in acute lung injury (ALI), sponsored by Imperial College London. Started Aug 2007; status: completed.
02
Drugs
acetylcysteine
03
Conditions
acute lung injury (ALI)
Beyond the preview
Go deeper on NCT00655928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00655928.